首页> 外文期刊>Investigative ophthalmology & visual science >Biosynthetic Corneal Implants for Replacement of Pathologic Corneal Tissue: Performance in a Controlled Rabbit Alkali Burn Model
【24h】

Biosynthetic Corneal Implants for Replacement of Pathologic Corneal Tissue: Performance in a Controlled Rabbit Alkali Burn Model

机译:生物合成角膜植入物替代病理性角膜组织:在受控兔碱烧伤模型中的性能。

获取原文
获取外文期刊封面目录资料

摘要

Purpose.: To evaluate the performance of structurally reinforced, stabilized recombinant human collagen-phosphorylcholine (RHCIII-MPC) hydrogels as corneal substitutes in a rabbit model of severe corneal damage. Methods.: One eye each of 12 rabbits received a deep corneal alkali wound. Four corneas were implanted with RHCIII-MPC hydrogels. The other eight control corneas were implanted with either allografts or a simple cross-linked RHCIII hydrogel. In all cases, 6.25 mm diameter, 350 ??m thick buttons were implanted by anterior lamellar keratoplasty to replace damaged corneal tissue. Implants were followed for nine months by clinical examination and in vivo confocal microscopy, after which implanted corneas were removed and processed for histopathological and ultrastructural examination. Results.: Alkali exposure induced extensive central corneal scarring, ocular surface irregularity, and neovascularization in one case. All implants showed complete epithelial coverage by four weeks postoperative, but with accompanying suture-induced vascularization in 6 out of 12 cases. A stable, stratified epithelium with hemidesmosomal adhesion complexes regenerated over all implants, and subbasal nerve regeneration was observed in allograft and RHCIII-MPC implants. Initially acellular biosynthetic implants were populated with host-derived keratocytes as stromal haze subsided and stromal collagen was remodeled. Notably, RHCIII-MPC implants exhibited resistance to vascular ingrowth while supporting endogenous cell and nerve repopulation. Conclusions.: Biosynthetic implants based on RHC promoted cell and nerve repopulation in alkali burned rabbit eyes. In RHCIII-MPC implants, evidence of an enhanced resistance to neovascularization was additionally noted.
机译:目的:评价结构增强的稳定化重组人胶原蛋白-磷酸胆碱(RHCIII-MPC)水凝胶作为严重角膜损伤兔子模型中角膜替代物的性能。方法:12只兔子每只的一只眼睛都受到深角膜碱伤。四个角膜植入了RHCIII-MPC水凝胶。其他八个对照角膜植入同种异体移植物或简单的交联的RHCIII水凝胶。在所有情况下,均采用前板层角膜移植术植入直径为6.25 mm,厚度为350 m的纽扣,以替换受损的角膜组织。通过临床检查和体内共聚焦显微镜对植入物进行九个月的随访,然后取出植入的角膜并进行处理以进行组织病理学和超微结构检查。结果:1例,暴露于碱导致广泛的中央角膜瘢痕形成,眼表不规则和新血管形成。术后四周所有植入物均显示完全上皮覆盖,但在12例中有6例伴随缝合线引起的血管形成。在所有植入物上均能生成稳定的,具有半桥粒粘附复合物的分层上皮,并且在同种异体移植物和RHCIII-MPC植入物中观察到了基底下神经的再生。最初,随着基质雾霾的消退和基质胶原的重塑,无细胞生物合成植入物中植入了宿主来源的角膜细胞。值得注意的是,RHCIII-MPC植入物在支持内源性细胞和神经再生的同时,表现出对血管向内生长的抵抗力。结论:基于RHC的生物合成植入物可促进碱烧兔眼中的细胞和神经重新聚集。在RHCIII-MPC植入物中,还另外发现了对新血管形成抵抗力增强的证据。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号